GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » KNC Laboratories Co Ltd (TSE:6568) » Definitions » Debt-to-EBITDA

KNC Laboratories Co (TSE:6568) Debt-to-EBITDA : N/A (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is KNC Laboratories Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

KNC Laboratories Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was 円609 Mil. KNC Laboratories Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was 円1,363 Mil. KNC Laboratories Co's annualized EBITDA for the quarter that ended in Sep. 2024 was 円0 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for KNC Laboratories Co's Debt-to-EBITDA or its related term are showing as below:

TSE:6568' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.47   Med: 0.94   Max: 3.26
Current: 0.94

During the past 9 years, the highest Debt-to-EBITDA Ratio of KNC Laboratories Co was 3.26. The lowest was 0.47. And the median was 0.94.

TSE:6568's Debt-to-EBITDA is ranked better than
72.16% of 1196 companies
in the Chemicals industry
Industry Median: 2.39 vs TSE:6568: 0.94

KNC Laboratories Co Debt-to-EBITDA Historical Data

The historical data trend for KNC Laboratories Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KNC Laboratories Co Debt-to-EBITDA Chart

KNC Laboratories Co Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only 0.94 0.94 0.90 0.50 0.65

KNC Laboratories Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.57 0.89 2.35 0.40 N/A

Competitive Comparison of KNC Laboratories Co's Debt-to-EBITDA

For the Chemicals subindustry, KNC Laboratories Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KNC Laboratories Co's Debt-to-EBITDA Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, KNC Laboratories Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where KNC Laboratories Co's Debt-to-EBITDA falls into.


;
;

KNC Laboratories Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

KNC Laboratories Co's Debt-to-EBITDA for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(658.347 + 1311.719) / 3024.907
=0.65

KNC Laboratories Co's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(608.751 + 1362.829) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2024) EBITDA data.


KNC Laboratories Co  (TSE:6568) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


KNC Laboratories Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of KNC Laboratories Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


KNC Laboratories Co Business Description

Traded in Other Exchanges
N/A
Address
Ohya Building. 6 Kandakonnyacho, 5th Floor, Chiyoda-ku, Tokyo, JPN, 101-0035
KNC Laboratories Co Ltd is an organic chemical and biochemical manufacturing company.

KNC Laboratories Co Headlines

No Headlines